Profiel
David Kao is Vice President-Regulatory Affairs at Inhibrx Biosciences, Inc. since 2021.
Former positions include Vice President-Regulatory Affairs at Sanofi AATD, Inc. from 2021 to 2024 and Head-Development Program at Bristol Myers Squibb Co. Education includes undergraduate studies at Rutgers State University of New Jersey, a doctorate from Shenandoah University, and an MBA from Rutgers Business School.
Actieve functies van David Kao
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van David Kao
| Bedrijven | Functie | Einde |
|---|---|---|
| INHIBRX, INC. | Algemeen Adviseur | 30-05-2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van David Kao
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenandoah University
Shenandoah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
















